Full Text View
Tabular View
No Study Results Posted
Related Studies
Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)
This study is enrolling participants by invitation only.
Study NCT01391182   Information provided by Mayo Clinic

First Received on July 7, 2011.   Last Updated on May 10, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Degenerative Joint Disease
Osteoarthritis
Additional conditions recognized in this trial
Hemorrhage
Joint Diseases
More general conditions related to this trial
Arthritis
Musculoskeletal Diseases
Pathologic Processes
Rheumatic Diseases
Interventions listed in this trial
EACA
Placebo arm
Additional drug interventions recognized in this trial
6-Aminocaproic Acid
More general drug interventions related to this trial
Antifibrinolytic Agents
Coagulants
Fibrin Modulating Agents
Hematologic Agents
Hemostatics
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services